Serum Institute purchases half stake in India’s biggest vial creator Schott Kaisha

Covishield COVID-19 vaccine creator Serum Institute of India (SII) has purchased a half stake in Schott Kaisha, the biggest producer of vials in India. Schott Kaisha is a 50:50 joint endeavor association between German claim to fame glass maker Schott and India’s Kaisha Manufacturers. SII’s CEO Adar Poonawalla said the arrangement will guarantee a continuous stock of fundamental pharma bundling items.

Most Popular